

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 53.27 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 25.36 | Oscillator | Neutral |
| Williams %R (14) | -74.07 | Oscillator | Neutral |
| MACD (12, 26, 9) | 0.56 (Hist -0.26) | Oscillator | Sell |
| Average Directional Index (14) | 27.31 (+DI 27.5 / -DI 19.1) | Trend | Strong Buy |
Current price $36.50
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 14, 26 |
TTM vs. 5-year historical average (annual ratios)
| Metric | AZTA | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -13.3x | -96.9x · sector 20.7x | Discount |
| Forward P/E (FY26E) | 114.8x | EPS est. 0.32 | Discount |
| Price / Book | 1.1x | 2.0x | Discount |
| Price / Sales | 2.6x | 6.5x | Discount |
| EV / EBITDA | -15.1x | 181.5x | Discount |
| Return on equity | -7.6% | — | Weak |
| Gross margin | 44.0% | 41.7% | In line |
| Debt / Equity | 0.04 | 0.04 | Conservative |
| Piotroski / Altman Z | 4/9 | Z 3.87 | Safe zone |
Discounted cash flow model
| EMA 20 | 35.99 | MA | Buy |
| SMA 20 | 36.58 | MA | Sell |
| EMA 50 | 34.20 | MA | Strong Buy |
| SMA 50 | 34.47 | MA | Strong Buy |
| SMA 200 | 28.34 | MA | Strong Buy |
| Needham |
| maintain |
| Buy |
| Buy |
| Aug 6, 26 | Evercore ISI Group | maintain | Outperform | Outperform |
| Aug 5, 26 | Needham | maintain | Buy | Buy |
| May 6, 26 | Needham | maintain | Buy | Buy |
| Apr 6, 26 | Evercore ISI Group | maintain | Outperform | Outperform |
| Mar 17, 26 | Needham | maintain | Buy | Buy |
| Feb 5, 26 | Evercore ISI Group | maintain | Outperform | Outperform |
| Feb 4, 26 | Needham | maintain | Buy | Buy |
| Feb 4, 26 | Jefferies | maintain | Buy | Buy |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Oct 23, 2026 | 2026-10-23 08:01:45 | View |
| 8-K | Oct 7, 2026 | 2026-10-07 08:01:12 | View |
| 4 | Sep 23, 2026 | 2026-09-23 10:24:20 | View |
| 8-K | Sep 17, 2026 | 2026-09-17 15:48:30 | View |
| 4 | Sep 16, 2026 | 2026-09-16 21:50:14 | View |
| 4 | Sep 16, 2026 | 2026-09-16 20:25:33 | View |
| 4 | Sep 16, 2026 | 2026-09-16 20:21:08 | View |
| 4 | Sep 16, 2026 | 2026-09-16 20:19:00 | View |
| 4 | Sep 16, 2026 | 2026-09-16 20:16:00 | View |
| 4 | Sep 16, 2026 | 2026-09-16 20:12:56 | View |
Proxy statement (DEF 14A) disclosures
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 22, 26 | Madaus Martin D | officer: Interim CEO | F-InKind | 1,294 @ $36.01 | $46.60K |
| Sep 22, 26 | Madaus Martin D | officer: Interim CEO | F-InKind | 1,456 @ $34.28 | $49.91K |
| Sep 14, 26 | Madaus Martin D | officer: Interim CEO | A-Award | 36,653 | — |
| Sep 14, 26 | Martin William E. Iii | officer: President Multiomics | A-Award | 15,272 | — |
| Sep 14, 26 | Pirogova Olga | officer: SVP and CHRO | A-Award | 15,272 | — |
| Sep 14, 26 | Lin Lawrence Y. | officer: EVP, CFO and Treasurer | A-Award | 30,544 | — |
| Sep 14, 26 | Starr Ephraim | officer: SVP, Gen Counsel & Secretary | A-Award | 15,272 | — |
| Sep 15, 26 | Bello Erik J. | officer: VP Chief Accounting Officer | A-Award | 4,586 | — |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Stock news · updated daily
New York, New York--(Newsfile Corp. - October 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
New York, New York--(Newsfile Corp. - October 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | 0.11 | 0.16 | Beat 40.6% | $161.2M |
| May 6, 2026 | 0.10 | -0.04 | Miss -140.0% | $144.8M |
| Feb 4, 2026 | 0.11 | 0.09 | Miss -18.2% | $148.6M |
| Nov 21, 2025 | 0.19 | 0.21 | Beat 10.8% | $159.2M |
| Aug 5, 2025 | 0.13 | 0.19 | Beat 46.2% | $143.9M |
| May 7, 2025 | 0.09 | 0.05 | Miss -44.4% | $143.4M |